UPDATE: Jefferies Downgrades Pfizer on Challenges Ahead
July 12, 2013 at 08:54 AM EDT
In a report published Friday, Jefferies analyst Jeffrey Holford downgraded the rating on Pfizer (NYSE: PFE ) from Buy to Hold, and lowered the price target from $32.00 to $30.00. In the report, Jefferies noted, “Rising rate expectations had the expected impact on the sector, which has been driven by
